HSBC DIS.CERT. 02/25 FRE/ DE000HS7VV29 /
09/01/2025 21:35:41 | Chg.0.000 | Bid21:59:09 | Ask21:59:09 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
23.890EUR | 0.00% | 23.860 Bid Size: 2,000 |
23.960 Ask Size: 2,000 |
FRESENIUS SE+CO.KGAA... | - EUR | 28/02/2025 | Call |
GlobeNewswire
24/04/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/04/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23/02/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil